Flannelly Barry P
SEC insider (Form 3/4/5 filer). CIK 0001615842. Director at Protara Therapeutics, Inc. (TARA) and 1 other issuer. 20 reported Form 4/5 transactions since Sep 2024; latest on Jun 15, 2026. Located in NEW YORK, NY.
Companies Flannelly Barry P has filed insider reports for
- Protara Therapeutics, Inc. (TARA): Director
- INCYTE CORP (INCY): Officer, EVP & General Manager US
Flannelly Barry P
CIK: 0001615842
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (20 total)
- Jun 15, 2026TARA
Protara Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
31K shares- - Jul 16, 2025INCY
INCYTE CORP
SaleDirect1.3K shares at avg. $68.36$92K - Jul 15, 2025INCY
INCYTE CORP
SaleDirect1.2K shares at avg. $69.86$83K - Jul 15, 2025INCY
INCYTE CORP
Tax PaymentDirect1.1K shares at avg. $68.25$78K - Jul 14, 2025INCY
INCYTE CORP
Tax PaymentDirect922 shares at avg. $69.98$65K - Jul 3, 2025INCY
INCYTE CORP
SaleDirect10.9K shares at avg. $68.15$743K - Jul 2, 2025INCY
INCYTE CORP
Tax PaymentDirect9.1K shares at avg. $68.17$617K - Jun 12, 2025TARA
Protara Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
24K shares- - Apr 1, 2025INCY
INCYTE CORP
AwardDirect11.2K shares- - Apr 1, 2025INCY
INCYTE CORP
AwardDirect15K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 15, 2026 | TARA Protara Therapeutics, Inc. | Award Stock Option (Right to Buy) | 31,000 | - | - | Direct |
| Jul 16, 2025 | INCY INCYTE CORP | Sale | 1,340 | $68.36 | $91,602 | Direct |
| Jul 15, 2025 | INCY INCYTE CORP | Sale | 1,192 | $69.86 | $83,273 | Direct |
| Jul 15, 2025 | INCY INCYTE CORP | Tax Payment | 1,141 | $68.25 | $77,873 | Direct |
| Jul 14, 2025 | INCY INCYTE CORP | Tax Payment | 922 | $69.98 | $64,522 | Direct |
| Jul 3, 2025 | INCY INCYTE CORP | Sale | 10,903 | $68.15 | $743,039 | Direct |
| Jul 2, 2025 | INCY INCYTE CORP | Tax Payment | 9,055 | $68.17 | $617,279 | Direct |
| Jun 12, 2025 | TARA Protara Therapeutics, Inc. | Award Stock Option (Right to Buy) | 24,000 | - | - | Direct |
| Apr 1, 2025 | INCY INCYTE CORP | Award | 11,159 | - | - | Direct |
| Apr 1, 2025 | INCY INCYTE CORP | Award | 14,976 | - | - | Direct |
1-10 of 20 transactions